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Abstract
Few Quantitative Structure-Activity Relationship (QSAR) studies have successfully modeled large,
diverse rodent toxicity endpoints. In this study, a comprehensive dataset of 7,385 compounds with
their most conservative lethal dose (LD50) values has been compiled. A combinatorial QSAR
approach has been employed to develop robust and predictive models of acute toxicity in rats caused
by oral exposure to chemicals. To enable fair comparison between the predictive power of models
generated in this study versus a commercial toxicity predictor, TOPKAT (Toxicity Prediction by
Komputer Assisted Technology), a modeling subset of the entire dataset was selected that included
all 3,472 compounds used in the TOPKAT’s training set. The remaining 3,913 compounds, which
were not present in the TOPKAT training set, were used as the external validation set. QSAR models
of five different types were developed for the modeling set. The prediction accuracy for the external
validation set was estimated by determination coefficient R2 of linear regression between actual and
predicted LD50 values. The use of the applicability domain threshold implemented in most models
generally improved the external prediction accuracy but expectedly led to the decrease in chemical
space coverage; depending on the applicability domain threshold, R2 ranged from 0.24 to 0.70.
Ultimately, several consensus models were developed by averaging the predicted LD50 for every
compound using all 5 models. The consensus models afforded higher prediction accuracy for the
external validation dataset with the higher coverage as compared to individual constituent models.
The validated consensus LD50 models developed in this study can be used as reliable computational
predictors of in vivo acute toxicity.
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1. Introduction
Chemical toxicity can be associated with many hazardous biological effects such as gene
damage, carcinogenicity, or induction of lethal rodent or human diseases. It is important to
evaluate the toxicity of all commercial chemicals, especially the High Production Volume
(HPV)1 compounds as well as drugs or drug candidates, since these compounds could directly
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affect human health. To address this need, standard experimental protocols have been
established by chemical industry, pharmaceutical companies, and government agencies to test
chemicals for their toxic potential. For example, a so called “Standard Battery for Genotoxicity
Test” was established by the International Conference on Harmonization, U. S. Environmental
Protection Administration (EPA), U. S. Food and Drug Administration (FDA) and other
regulatory agencies. This test includes one bacterial reverse mutation assay (e.g. Salmonella
typhimurium mutation test), one mammalian cell gene mutation assay (e.g., mouse lymphoma
cell mutation test) and one in vivo micronucleus test. The test battery varies slightly for
pharmaceutical compounds, industrial compounds, and pesticides. The current strategies and
guidelines for toxicity testing were described in a recent review (1).
Although the experimental protocols for toxicity testing have been developed for many years
and the cost of compound testing has been reduced significantly, computational chemical
toxicology continues to be a viable approach to reduce both the amount of effort and the cost
of experimental toxicity assessment (2). Significant savings could be achieved if accurate
predictions of potential toxicity could be used to prioritize compound selection for
experimental testing, especially for testing in vivo.
Many Quantitative Structure Activity Relationship (QSAR) models have been developed for
different toxicity endpoints to address this challenge (3–6). The summary of several models
reported in earlier publications on acute rodent toxicity are given in Table 1. There are several
shortcomings of earlier toxicity QSAR models that should be pointed out. Most of these studies
included a relatively small number of congeneric compounds and as a result, they had limited
applicability for compounds outside of the modeling set. Very few successful QSAR models
have been reported for predicting in vivo toxicity endpoints that are applicable to the diverse
compounds of environmental interest (5,7,8). For instance, Enslein and coworkers (9,10)
developed multi-linear regression models using large, diverse training sets (425 and 1851
chemicals, respectively) but these models had relatively poor external prediction power,
yielding an R2 value of 0.33 for the large test set.
Indeed, accurate prediction of toxicity for compounds that were not used for model
development is a very challenging problem. QSAR models are generally more applicable for
the analysis of small datasets of similar compounds with a simple mechanism of action (e.g.,
congeneric molecules binding to the same receptor or inhibiting the same enzyme) and less
accurate for larger dataset of compounds with complex mechanisms of action. Toxicity
prediction is a hard problem because there are multiple underlying mechanisms of action, and
the datasets studied in the context of a general end point (e.g., rat LD50) are large and chemically
diverse. Furthermore, QSAR models are developed by interpolating the training set data and
therefore they inherently have limited applicability outside of the training set. At the same time,
any external prediction implies inherent, and frequently, excessive extrapolation of the training
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set models. Poor external predictive power of QSAR models could be due to the lack of or
incorrect use of external validation during the modeling process. Each statistical method used
in QSAR studies has its particular advantages, weaknesses, and practical constraints so it is
important to select the most suitable QSAR methodology for a specific toxicity endpoint. Thus,
the toxicity prediction challenge should be addressed very carefully using rigorous modeling
approaches and extensive model validation procedures.
Our recent studies of aquatic toxicity offered potential solutions to some of the above problems
(11). A combinatorial QSAR approach was applied to study an aquatic toxicity dataset
containing 983 diverse organic compounds tested against Tetrahymena pyriformis (11). To
explain our choice of methodology and terminology, any QSAR modeling effort requires a set
of chemical descriptors and a statistical optimization approach to develop the best correlation
between values of descriptors and those of biological activity. For any dataset there are several
sets of descriptors that could be calculated using different available software packages.
Similarly, there are multiple statistical modeling approaches that could be employed with any
of the descriptor sets. In the practice of QSAR modeling, there is no standard combination of
the descriptor type and model optimization approach that works best for all datasets. In addition
different QSAR methods usually use different definitions of applicability domain (or in most
cases do not use the applicability domain at all). Combinatorial QSAR modeling implies that
for a given experimental dataset we calculate several sets of descriptors and employ several
statistical modeling approaches forming all-against-all pairwise combinations of descriptor
sets and modeling techniques to develop multiple types of QSAR models. We require that each
model must satisfy certain validation criteria. As we demonstrated in the earlier study (11), the
consensus models had the highest external prediction power as compared to any individual
model used in the consensus prediction. Since the individual models can have differently
defined applicability domains, the consensus method can also afford greater chemical space
coverage as well.
In this paper, a similar combinatorial QSAR workflow was employed to study a much larger
and more chemically diverse dataset (arguably, the largest and most diverse in vivo toxicity
dataset ever reported in the public domain) containing 7,385 unique organic compounds with
experimentally determined oral rat acute toxicity. We have explored various QSAR approaches
in terms of their ability to develop robust and externally predictive models. The consensus
prediction integrating all validated individual models was found to be the most accurate (using
an external prediction set) when compared both to each individual model used in the consensus
approach and to a popular commercial software, TOPKAT. The consensus models developed
in this study could be used as reliable predictors of rodent acute toxicity for chemical
compounds. The models will be made available through the ChemBench web portal maintained
in our laboratory (http://chembench.mml.unc.edu).
2. Methods
2.1. Datasets
The rat LD50 data were collected from difference sources (12) to form a dataset including more
than 8,000 compounds. The structures of those compounds were verified using the approach
discussed by Young’s group (13). The quality of the data has been extensively reviewed over
the past several years. After removing inorganic and organometallic compounds, salts, and
compound mixtures, the final acute toxicity dataset included 7,385 unique organic compounds.
The original values of LD50 for each compound were expressed as mol/kg; these were
converted to log(1/(mol/kg)) values according to standard QSAR practices. Chemical
structures of all compounds and their experimental LD50 values used in this study are available
from the authors upon request.
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This dataset was compared with the training set used to develop the rat acute toxicity predictor
available from the commercial Toxicity Prediction by Komputer Assisted Technology
(TOPKAT) software. It was found that 3,472 out of 7,385 compounds were included in the
TOPKAT rat LD50 training database. To enable direct comparison of external predictive power
for models generated in our studies vs. TOPKAT), these 3,472 compounds were used as the
modeling set and the remaining 3,913 compounds as the external validation set.
2.2. QSAR Modeling Approaches
2.2.1. Descriptors—Rat LD50 models for the 3,472 modeling set compounds were
developed with various types of chemical descriptors, including those from the Dragon
software v5.4 (14) and a set of descriptors developed previously by Martin and coworkers at
the US EPA (15). The latter set consisted of more than 800 descriptors in the following classes:
E-state values and E-state counts, constitutional descriptors, topological descriptors, walk and
path counts, connectivity, information content, 2D autocorrelation, Burden eigenvalues,
molecular properties (such as the octanol-water partition coefficient), Kappa, hydrogen bond
acceptor/donor counts, molecular distance edge, and molecular fragment counts. There were
overlaps between Dragon and EPA descriptors but both included unique types of descriptors
as well. The Dragon descriptors were used for the kNN and random forest methods and the
EPA descriptors were used for the hierarchical clustering, FDA MDL QSAR, and nearest
neighbor QSAR methods.
Initial use of Dragon yielded more than a thousand of chemical descriptors for the training set,
which were processed as follows. First, we removed all descriptors that had zero values or zero
variance for all modeling set compounds. Furthermore, redundant descriptors were identified
by analyzing correlation coefficients between all pairs of descriptors and if the correlation
coefficient between two descriptor types for all modeling set compounds was higher than 0.95,
one of them was removed. As a result, the total number of Dragon descriptors used for model
building was reduced to 454. The number of EPA descriptors used for model building (for the
hierarchical clustering and FDA MDL QSAR methods) varied depending on the size and
composition of the training set molecules that were used for model building.
2.2.2. kNN—The kNN QSAR method (16) employs the kNN classification principle and a
variable (i.e., descriptor) selection procedure. Briefly, a subset of nvar (number of selected
descriptors) descriptors is selected randomly at the onset of the calculations. The nvar is set to
different values and the training set models are developed with leave-one-out cross-validation,
where each compound is eliminated from the training set and its LD50 value is predicted as the
average activity of k most similar molecules, where the value of k is optimized as well (k = 1
to 5). The similarity is characterized by Euclidean distance between compounds in
multidimensional descriptor space. A method of simulated annealing with the Metropolis-like
acceptance criteria is used to optimize the selection of descriptors. The objective of this method
is to optimize nvar and k values to obtain the best leave-one-out cross-validated q2abs, i.e.,
q2 with the intercept set to zero, possible by optimizing the nvar and k. The additional details
of the method can be found elsewhere (16).
In developing kNN QSAR models we followed our general predictive QSAR modeling
workflow methodology (17), that places special emphasis on model validation. Briefly, we
start by dividing the original dataset randomly into a (bigger) modeling set and a (smaller)
external validation set; the latter is not used for model development at all and the former is
designated as a modeling set. The modeling set compounds are divided multiple times into
training/test sets using the Sphere Exclusion approach (18) that ensures that both training and
test sets are chemically diverse The models are developed using training set data and their
performance is characterized with the standard leave-one-out cross-validated (LOO-CV) R2
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(q2) for the training sets and the conventional coefficient of determination R2 for the test sets;
this coefficient is determined for a regression that is forced through the origin of the
experimental vs. calculated LD50 plot. The model acceptability threshold values of the LOO-
CV accuracy of the training sets and the prediction accuracy for test sets were both set at no
less than 0.5. Models that did not meet both training and test set cutoff criteria were discarded.
Models that passed these threshold criteria were used to predict LD50 values of the external
validation set to assure their external predictive power as discussed in the Results section. The
detailed discussion of the workflow used to develop validated QSAR models can be found in
a recent review (19).
2.2.3. Random Forest—In machine learning, a random forest is a predictor that consists of
many decision trees and outputs the prediction that combines outputs from individual trees.
The algorithm for inducing a random forest was developed by Breiman and Cutler (20). In this
study, the implementation of the random forest algorithm available in R.2.7.1 (21) was used.
In the random forest modeling procedure, n samples are randomly drawn from the original
data. These samples were used to construct n training sets and to build n trees. For each node
of the tree, m descriptors were randomly chosen from the total 454 Dragon descriptors. The
best data split was calculated using these m descriptors for each training set. In this study, only
the defined parameters (n = 500 and m = 13) were used for the model development.
2.2.4. Hierarchical Clustering—The hierarchical clustering method utilizes a variation of
the Ward’s Minimum Variance Clustering Method (22) to produce a series of clusters from
the initial training set. For a training set of n chemicals, initially there will be n clusters. At
each step in the clustering process, two clusters are combined so that the increase in variance
over all the clusters in the system is minimized. The change in variance caused by combining
clusters j and k is as follows:
[1]
where nj = number of chemicals in cluster j, Cj,i is the centroid (or average value) for descriptor
i for cluster j, and d is the number of descriptors in the EPA pool of descriptors (~800) (15).
The process of combining clusters while minimizing variance continues until all of the
chemicals are lumped into a single cluster. After the clustering is complete, each cluster is
analyzed to determine if an acceptable QSAR model can be developed. A genetic algorithm
technique is used to select descriptors to build a multi-linear regression model for each cluster
(15). Similar to the kNN approach, each model must achieve a LOO-CV accuracy of 0.5 to be
used in making predictions. The predicted value for a given test chemical is calculated using
the equally weighted average of the model predictions from the closest cluster from each step
in the hierarchical clustering. This method was previously shown to yield the best results for
another acute toxicity endpoint, IGC50 (50% inhibitory concentration of population growth)
of Tetrahymena pyriformis (15).
2.2.5. FDA MDL QSAR Method—A QSAR methodology (denoted here as the FDA MDL
QSAR method) based on the studies of Contrera et al. (23) was developed earlier (15). For
each test chemical, a cluster is constructed using the thirty most similar chemicals from the
training set as defined by the cosine similarity coefficient, SCi,k, which is calculated as follows
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where xij is the value of the jth normalized descriptor for chemical i (normalized with respect
to all the chemicals in the original training set) and xkj is the value of the jth descriptor for
chemical k. The entire pool of approximately 800 EPA descriptors is used to calculate the
similarity coefficient in equation 2. A multiple linear regression model is then built for the new
cluster using a genetic algorithm based method and the toxicity is predicted.
2.2.6. Nearest Neighbor Method—The nearest neighbor method is a simplification of the
variable selection kNN approach described above. In the nearest neighbor method, the toxicity
is simply predicted as the average of the toxicity of the three most similar chemicals from the
training set. The similarity is defined in terms of the cosine similarity coefficient (Equation 2).
In the nearest neighbor method, the entire available descriptor pool is used to characterize
molecular similarity (as opposed to a subset of the descriptor pool as in the descriptor selection
kNN method). In order to make a prediction, each of the neighbors in the training set must
exceed a minimum cosine similarity coefficient of 0.5.
2.3. Identification of Outliers in the Dataset
A common problem for most QSAR studies is the existence of compounds that are highly
dissimilar to all other compounds in the dataset. These compounds are regarded as outliers in
the descriptor space and are likely to present problems in establishing SAR trends, which is
critical to QSAR modeling. In this study, we have identified and excluded the structural outliers
from the modeling at the beginning of the modeling procedure.
For kNN and random forest modeling procedures, we have developed a method to detect
outliers that are dissimilar to other compounds of the dataset in the descriptor space. This
procedure included the following steps. 1) calculation of the distance or similarity matrix based
on the Dragon descriptors of compounds in the descriptor space; 2) finding the nearest
neighbors for all compounds in the dataset based on a predefined similarity threshold; 3)
identifying those compounds that have no nearest neighbors as outliers.
In order to measure similarity, each compound i is represented by a point in the M-dimensional
descriptor space (where M is the total number of descriptors) with the coordinates Xi1, Xi2, …,
XiM, where Xis (s=1 ,…,M) are the values of individual descriptors. The molecular dissimilarity
between any two molecules i and j is characterized by the Euclidean distance between their
representative points. The Euclidean distance dij between points i and j in M-dimensional space
can be calculated as follows (Eq. 3):
[3]
Compounds with the smallest distance between them are considered to have the highest
similarity. The distances (dissimilarity) of compounds in our modeling set are compiled to
produce a chemical similarity threshold DT, calculated as follows (Eq.4):
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Here, ȳ is the average Euclidean distance between all compounds and their k nearest neighbors
(k was set to 1 in this procedure) of each compound within the modeling set, σ is the standard
deviation of these Euclidean distances, and Z is an arbitrary parameter to control the threshold
level and was set to 0.5 in this study. The DT threshold is used to identify outliers as follows.
If the distance of a compound to its nearest neighbor in the modeling set exceeds this threshold,
this compound is considered an “outlier” and excluded from the modeling set. After excluding
997 structural outliers, the remaining 2,475 modeling set compounds were compiled as a new
reduced modeling set to develop kNN and random forest toxicity models.
It is important to point out that the identification and exclusion of outliers is based only on
consideration of chemical similarity but not activity. Thus, the removal of structural outliers
could be regarded as a pre-treatment of the modeling set using objective chemometric
approaches.
For the hierarchical and FDA MDL QSAR methods, a chemical is removed from a cluster if
it is both an influential data point (determined by at least two statistical tests, e.g. DFFITS,
leverage, Cook’s distance, and covariance ratio) and an outlier (determined from studentized
deleted residual). The details of these procedures are given elsewhere (24).
2.4. Model Applicability Domains
Defining model Applicability Domains (AD) is an active area of modern QSAR research
(25,26). Every QSAR model can formally predict the relevant target property for any compound
for which chemical descriptors can be calculated. However, since each model is developed
using compounds in the training set only (that cover only a small fraction of the entire chemistry
(i.e., descriptor) space) the special applicability domain for each model should always be
defined. As a consequence, only a certain fraction of compounds in any external dataset is
expected to fall within the AD. This fraction is therefore referred to as the dataset coverage.
There are several discussions about model AD in a recent publication (27). In this study, we
present a detailed discussion concerning the effect of the AD on model predictivity using much
larger modeling/validation sets than any other reported in the literature including our own
previous publications.
2.4.1. Applicability Domain of kNN and Random Forest—The AD of kNN and
Random Forest models is calculated from the distribution of similarities between each
compound and its k nearest neighbors in the training set (similarities are computed as Euclidean
distances between compounds represented by their multiple chemical descriptors). Based on
the previous studies, the standard cutoff value to define the applicability domain for a QSAR
model places its boundary at one-half of the standard deviation calculated for the distribution
of distances between each compound in the training set and its k nearest neighbors in the same
set. Thus, if the distance of the test compound from any of its k nearest neighbors in the training
set exceeds the threshold, the prediction is considered unreliable. The detailed description of
the algorithm to define this AD is given elsewhere (18,28).
2.4.2. Applicability Domain of the Hierarchical method—Before any cluster model
can be used to make a prediction for a test chemical, it must be determined whether the test
chemical falls within the AD for the model. The first constraint, the model ellipsoid constraint,
checks if the test chemical is within the multidimensional ellipsoid defined by the ranges of
descriptor values for the chemicals in the cluster (for the descriptors appearing the cluster
model). The model ellipsoid constraint is satisfied if the leverage of the test compound (h00)
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is less than the maximum leverage value for all the compounds used in the model (29). The
second constraint, the Rmax constraint, checks if the distance from the test chemical to the
centroid of the cluster is less than the maximum distance for any chemical in the cluster to the
cluster centroid. The final constraint, the fragment constraint, stipulates that the chemicals in
the cluster must contain at least one example of each of the fragments that are present in the
test chemical (15).
2.4.3. Applicability Domain of the FDA MDL QSAR method—For the prediction from
the cluster model to be valid, several constraints must be met. The first two constraints are the
model ellipsoid and fragment constraints described above. The final constraint is that the
predicted toxicity value must be within the range of experimental toxicity values for the
chemicals used to build the model (15).
2.4.4. Applicability Domain of the Nearest Neighbor Method—For a prediction from
the nearest neighbor method to be made, there must be three chemicals in the training set which
are sufficiently similar to the test chemical (the similarity coefficient between each chemical
and the test chemical in equation 1 must exceed 0.5).
3. Results and Discussions
3.1. Individual LD50 Models
The statistical parameters of predictions for the external validation set obtained from all five
QSAR models developed in this study as well as using TOPKAT are shown in Table 2. It is
difficult to compare all models side by side because the underlying approaches used different
definitions of AD and therefore the statistical results are shown for external datasets of different
sizes. Indeed, these initial results suggest that the prediction accuracy and chemical space
coverage are tightly interlinked and in general, as expected, higher accuracy is obtained for
smaller external datasets within the AD of each model. Models with the most liberally defined
AD (and consequently, the highest coverage), i.e., NN and FDA MDL QSAR had the lowest
R2 and the highest MAE followed by TOPKAT and Hierarchical Clustering that had
progressively higher R2 values (although similar MAE) and smaller coverage. Nevertheless,
for these four models the absolute R2 values were relatively low, i.e., under 0.5. Only two
models (kNN and RF) afforded R2 higher than 0.50 and MAE lower than 0.50 for the external
validation set but the external dataset coverage of these two models is the lowest (19%) among
all models. It could be argued that for this dataset (and perhaps for any large and diverse dataset)
it is critical to define a rather restrictive AD in order to achieve most accurate predictions as
discussed in more detail below.
3.2. Effect of the Model Applicability Domain
All five QSAR approaches implemented method-specific AD except kNN and RF models,
which used the same definition of AD. On average, the use of AD improved the performance
of individual models although the improvement came at the expense of the lower chemical
space coverage. The direct comparison between individual models appears difficult due to
different definitions of AD and different interplay between coverage and accuracy for relevant
models.
Figure 1 shows the distribution of MAE values for the prediction of external validation set for
TOPKAT, five individual models and consensus model developed in this study (see additional
discussion of the consensus model below) that used the AD for three compound sets: all external
compounds; those located within the AD of each model; and those outside of AD. Notably, all
models showed similar predictivity when applied to the entire external set but the effect of AD
was indeed model-specific. Six (TOPKAT, kNN, RF, Hierarchical Clustering, FDA MDL
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QSAR and consensus) out of seven QSAR models that used the AD showed the improvement
in the prediction accuracy for external validation set as a result of excluding those compounds
outside of the AD. The result of NN practically did not change after applying the AD criteria.
This is not surprising given that there were only very few compounds that were outside of the
structural AD in this model.
The different predictivity of the external validation set obtained from five QSAR models does
not necessarily indicate that statistical approaches or descriptors used to develop these models
have greatly different predictive power for this specific toxicity endpoint. It is noticeable that
the resulting predictive accuracy strongly correlates to the model coverage that is decided by
the model applicability domain. Once a more restrictive AD was applied, the predictive
accuracy improved significantly (Table 2). For this reason, it is interesting to study the
performance of each model when the same model applicability domain was implemented.
Since only a small number of compounds were out of the ADs of NN and FDA MDL QSAR
models, the remaining two model applicability domains (ADs of Hierarchical Clustering and
kNN/RF) and the AD of TOPKAT were used to study the prediction accuracy of each model
under the same prediction coverage (Table 3).
When using the same model applicability domain, the prediction coverage of the external
prediction set obtained from each individual QSAR models are almost but not exactly the same.
This is because there are some compounds (less than 1% of the total external compounds)
which cannot be predicted using the Hierarchical clustering method even if all the constraints
are relaxed. At similar levels of prediction coverage, the individual predictions using models
generated in this study are similar to each other. Interestingly, the results generated using all
models are approximately the same (in terms of R2 and MAE) when using TOPKAT defined
AD, with kNN method arguably showing slightly better performance. However, somewhat
surprisingly, with the decrease of the chemical space coverage most of the individual models
developed in this study appear increasingly superior to TOPKAT (Table 3). It may be
concluded that the prediction accuracy is not sensitive to the statistical approaches employed
in this paper but strongly depends on the model applicability domain. Again, as noted above,
it could be concluded that the higher accuracy of prediction comes at the expense of reducing
the chemical space coverage.
3.3. Compounds that Can Not Be Correctly Predicted by Individual Models
There are some compounds that could not be predicted accurately by any of the five individual
models. Using MAE > 1.0 as criteria, there are 520 validation set compounds with large
prediction errors for any of the individual models. Some specific chemical scaffolds could be
identified from these 520 compounds. These scaffolds and the comparison between the average
LD50 values of the associated compounds in the modeling set, external validation set and those
validation set compounds that have large prediction errors are listed in Table 4. The average
LD50 value of these compounds is 3.4, and it is much higher than that of the compounds in the
modeling set (2.47). Therefore, the relatively small fraction of compounds with high values of
acute toxicity in the modeling set is a potential reason of the low prediction accuracy for these
520 compounds.
Ten out of 17 steroid-like compounds in the validation set have large prediction errors. As
shown in Table 4, the five steroids in the modeling set have lower acute toxicity (average
LD50 = 2.5) than these ten compounds (average LD50 = 4.6). A similar observation is true for
the esters. Compounds with the same scaffolds and high acute toxicity need to be added into
the modeling set to accurately predict these types of compounds. On the contrary, all five
dioxins in the validation set have much lower toxicity (average LD50 = 5.1) than those three
in the modeling set (average LD50 = 8.2). Therefore, dioxins with lower acute toxicity need to
be added to the modeling set to accurately predict this type of compounds. There is no clear
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difference between the average LD50 value of 49 thiophosphates with large prediction errors
in the validation set and the 285 thiophospates in the modeling set. However, the activity range
of these 49 thiophosphates in the validation set is from 1.2 to 6.3, which is much larger than
the activity range of 285 thiophospates in the modeling set, which is from 1.6 to 5.4. For this
reason, thiophosphates with both high and low acute toxicity values need to be added to the
validation set to improve the model predictivity for this type of compounds. These results
indicate the existing shortcomings of the TOPKAT LD50 modeling set. Apparently, the
modeling set should be balanced not only in terms of chemical diversity of compounds but
also their activity distribution to afford higher external accuracy of models.
3.4. Consensus Modeling
The statistical results obtained with individual models indicate that different modeling
techniques may have different advantages for predicting the rat oral LD50 of organic
compounds. Although the performance of our individual models are comparable or slightly
better than that of TOPKAT, it is difficult to judge which model is better than others and which
model should be chosen to predict rat acute toxicity potential of new compounds. For this
reason, following a strategy that was proven successful in our previous studies (11) a simple
consensus model was developed that integrated all of the individual models. In this approach,
the LD50 value for each compound is predicted as the arithmetic average of all LD50 values
predicted by individual models taking into account the model applicability domains. Note that
additional averaging schemes giving, e.g., different weights to different contributing models
could be used in principle. However, there has not been sufficient research in the QSAR
modeling community into looking for the most optimal scheme for the ensemble QSAR
modeling. Thus, we chose the simplest approach in this study. The detailed comparison
between consensus predictions and those of other models when using the same AD is listed in
Table 3. The data clearly demonstrate that the predictive accuracy of consensus model is higher
than that for any individual model. In addition, we used the Wilcoxon test to calculate the p-
values for the differences in MAEs obtained by consensus prediction vs. individual methods.
Under almost all conditions, the improvement achieved by consensus prediction, compared
with any individual model, is statistically significant (p < 0.01) and the only exception is when
comparing consensus prediction with RF for the 743 compounds in the applicability domain
of RF models (p=0.4).
From the discussion above, it is clear that the AD is an important factor that affects the
predictive accuracy of each individual model. In the consensus prediction, model applicability
domain was implemented by introducing the concept of “consensus prediction fraction”. Since
the consensus prediction is the average of predictions using all five models, the fraction of the
prediction could be defined as the number of individual model predictions that are available
to predict a new compound (due to the AD limitations). Thus, if only one model could predict
a compound, the consensus prediction fraction is 20% for this compound. If all 5 models could
make the prediction, the prediction fraction of the consensus model is 100%. Different cutoff
values for the prediction fraction could be set to get different prediction accuracy (and different
coverage) based on this threshold. Figure 2 shows the change of prediction accuracy of external
set, which is indicated by R2 and MAE, obtained by consensus prediction with different fraction
cutoff values (Figure 2). For comparison, the TOPKAT prediction for the same external
compounds is also shown in the same Figure 2. Increasing the prediction fraction level
increased the prediction accuracy but decreased the prediction coverage. Figure 3 shows the
relationship between experimental and consensus-predicted LD50 values when the prediction
fraction is 80%. The compounds outside of the AD in this consensus prediction are also shown
(Figure 3). Obviously, the removal of outliers improves the correlation. Furthermore, it is also
interesting to compare the prediction coverage and accuracy that is indicated by R2 and
MAE. Figure 4 shows the inverse correlation between the coverage and R2 (or direct correlation
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between the coverage and MAE) for all individual models (including TOPKAT) and consensus
model (including the results of different prediction fractions). It is clear that the prediction
accuracy obtained by this consensus model is higher than that for any individual model under
any conditions (Figure 4).
A further understanding of the predictive ability of the models used in this study can be obtained
by analyzing compounds for which consensus prediction gave higher accuracy than any of the
individual models. It is clear that if all five individual models make similar predictions for a
compound, the value from consensus prediction will be similar to any of those generated with
individual models. The possible improvement of the prediction accuracy due to the use of
consensus prediction could be achieved when the individual predictions are different. Table 5
lists ten compounds, which have the most significant difference between individual predictions.
There are many external validation set compounds (such as #1, #4, #5 and #9 in Table 4) whose
individual LD50 predictions include one value with a large deviation from the others, which is
usually the one that has the largest prediction error. Therefore, by taking the average for
consensus prediction, we could compensate for the large error of such individual result.
On the other hand, the compounds #2, #3, #6, #7, #8 and #10 show large errors for the majority
of their individual predictions. The consensus model is able to make accurate prediction, such
as for compound #8, or prediction with moderate error, as for the remaining compounds in the
Table, because individually predicted LD50 values are both lower and higher than the
experimental LD50 value so that the errors to some extent cancel each other. The differences
in model predictions arise because they use different descriptors and/or different modeling
methods, which could model different aspects of toxicological affects. Thus, the consensus
modeling allows for these different affects to be incorporated into a single (and on average,
more accurate) prediction.
4. Conclusions
Several QSAR approaches have been used to develop toxicity models of the largest available
set of diverse organic compounds tested for the oral acute toxicity in rats. The resulting models
(for the most part incorporating specific applicability domains) were validated by predicting
the toxicity of a large external validation set. It was observed that all models showed somewhat
different but comparable performance for the validation set when compared to the commercial
toxicity predictor TOPKAT. Formally, the highest accuracies were achieved by kNN and RF
approaches (R2 = 0.66 and 0.70, respectively) but this required a decrease in space coverage
(to ca. 19%). However, when the same model applicability domain was implemented, the
individual models showed similar performance as applied to the validation set. Here, the use
of applicability domain improved the prediction accuracy using individual models but
decreased the predictive coverage of the validation set. Notably with the decrease of the
prediction coverage models developed in this study showed slightly higher prediction accuracy
as compared to TOPKAT.
The most significant result of our studies is the demonstrated superior performance of the
consensus modeling approach when all models are used concurrently and predictions from
individual models are averaged (see Figure 1)‥ The predictive accuracy of the consensus
QSAR models was shown to be superior to any individual model when predicting the same set
of external compounds. By using different cutoff values for the prediction fraction, trade-offs
between the accuracy and the coverage of consensus prediction results can easily be seen. The
predictivity of consensus models was found to be superior to that of TOPKAT when predicting
the same external compounds. Finally, these studies indicated that a well organized modeling
set that covers not only a broad chemical space but also broad activity ranges of major chemical
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scaffolds in this chemical space is necessary to develop successful QSAR toxicity predictors.
Additional studies of this dataset are ongoing and will be reported in the future. All successful
models reported in this paper will be made available via the ChemBench web portal
(http://chembench.mml.unc.edu). Meanwhile, interested researchers can send us any
compounds of interest for LD50 prediction.
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The MAEs of seven QSAR models for the external validation set. The AD of consensus model
was defined when the 80% prediction fraction was applied (see text for additional discussion).
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The prediction of external compounds by consensus model and TOPKAT with different
consensus prediction fraction levels.
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The correlation between experimental and consensus-predicted LD50s when the consensus
prediction fraction is 80% (i.e., compounds are within AD of four or more individual models).
Zhu et al. Page 17














The relationship between prediction coverage and (a) R2 or (b) MAE for the external
compounds.
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Statistical results obtained with all QSAR models for the external validation set of 3913
compounds.
Models R2 MAE Coverage(%)
kNN 0.66 0.44 19
RF 0.70 0.41 19
Hierarchical Clustering 0.41 0.58 66
NN 0.24 0.61 97
FDA MDL QSAR 0.29 0.60 95
TOPKAT 0.35 0.59 74
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